Covered recipient · General Payments record
ROSEMARY A MAHAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Pediatrics
General Payments · PY2021–2024
$2,453.66
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $462.80 | 6 |
| Consulting Fee | $29.93 | 1 |
| Education | $20.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $117.77 | 1 |
| GENZYME CORPORATION | $112.27 | 1 |
| Octapharma USA, Inc. | $89.03 | 3 |
| Genentech, Inc. | $89.00 | 1 |
| Y-mAbs Therapeutics, Inc. | $84.66 | 1 |
| CSL Behring | $20.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $117.77 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086281274 | CMS |
| CSL Behring | $20.00 | 02/06/2024 | Education | Undisputed | 01/23/2026 | 1134629357 | CMS |
| Genentech, Inc. | $89.00 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133183835 | CMS |
| GENZYME CORPORATION | $112.27 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139731846 | CMS |
| Octapharma USA, Inc. | $26.10 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142322714 | CMS |
| Octapharma USA, Inc. | $33.00 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142322716 | CMS |
| Octapharma USA, Inc. | $29.93 | 11/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142322718 | CMS |
| Y-mAbs Therapeutics, Inc. | $84.66 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142462113 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.